Kazia Therapeutics Ltd (KZIA)
0.3701
0.00 (0.00%)
USD |
NASDAQ |
Apr 26, 16:00
0.3701
0.00 (0.00%)
After-Hours: 20:00
Kazia Therapeutics Cash from Operations (Quarterly)
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2021 | -8.297M |
| September 30, 2021 | |
| December 31, 2020 | -8.972M |
| September 30, 2020 |
| Date | Value |
|---|---|
| December 31, 2007 | -8.018M |
| December 31, 2006 | -6.005M |
| December 31, 2005 | -4.700M |
| December 31, 2004 | -4.940M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-8.972M
Minimum
Dec 2020
-8.297M
Maximum
Dec 2021
-8.634M
Average
-8.634M
Median
Cash from Operations (Quarterly) Benchmarks
| Immutep Ltd | -- |
| Opthea Ltd | -- |
| Alterity Therapeutics Ltd | -- |
| Mesoblast Ltd | -16.28M |
| Immuron Ltd | -- |